207 related articles for article (PubMed ID: 30683713)
1. Transforming growth factor β (TGFβ) and related molecules in chronic kidney disease (CKD).
Huynh P; Chai Z
Clin Sci (Lond); 2019 Jan; 133(2):287-313. PubMed ID: 30683713
[TBL] [Abstract][Full Text] [Related]
2. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
3. TGFβ-incurred epigenetic aberrations of miRNA and DNA methyltransferase suppress Klotho and potentiate renal fibrosis.
Yin S; Zhang Q; Yang J; Lin W; Li Y; Chen F; Cao W
Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1207-1216. PubMed ID: 28285987
[TBL] [Abstract][Full Text] [Related]
4. TGF‑β/Smad signaling in chronic kidney disease: Exploring post‑translational regulatory perspectives (Review).
Li J; Zou Y; Kantapan J; Su H; Wang L; Dechsupa N
Mol Med Rep; 2024 Aug; 30(2):. PubMed ID: 38904198
[TBL] [Abstract][Full Text] [Related]
5. Acupuncture attenuates renal interstitial fibrosis via the TGF‑β/Smad pathway.
Zuo Z; Huang P; Jiang Y; Zhang Y; Zhu M
Mol Med Rep; 2019 Sep; 20(3):2267-2275. PubMed ID: 31322212
[TBL] [Abstract][Full Text] [Related]
6. Endoglin Is an Important Mediator in the Final Common Pathway of Chronic Kidney Disease to End-Stage Renal Disease.
Gerrits T; Brouwer IJ; Dijkstra KL; Wolterbeek R; Bruijn JA; Scharpfenecker M; Baelde HJ
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614087
[TBL] [Abstract][Full Text] [Related]
7. The cellular and signalling alterations conducted by TGF-β contributing to renal fibrosis.
Vega G; Alarcón S; San Martín R
Cytokine; 2016 Dec; 88():115-125. PubMed ID: 27599257
[TBL] [Abstract][Full Text] [Related]
8. The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury.
Anders HJ; Suarez-Alvarez B; Grigorescu M; Foresto-Neto O; Steiger S; Desai J; Marschner JA; Honarpisheh M; Shi C; Jordan J; Müller L; Burzlaff N; Bäuerle T; Mulay SR
Kidney Int; 2018 Mar; 93(3):656-669. PubMed ID: 29241624
[TBL] [Abstract][Full Text] [Related]
9. c‑Jun N‑terminal kinase/transforming growth factor‑β/Smad3 pathway: Is it associated with endoplasmic reticulum stress‑mediated renal interstitial fibrosis?
Liu Y; Shen P; Zhou Y; Tang L; Chai H
Mol Med Rep; 2019 Jul; 20(1):755-762. PubMed ID: 31180530
[TBL] [Abstract][Full Text] [Related]
10. Contribution of genetics and epigenetics to progression of kidney fibrosis.
Tampe B; Zeisberg M
Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv72-9. PubMed ID: 23975750
[TBL] [Abstract][Full Text] [Related]
11. ShenKang injection suppresses kidney fibrosis and oxidative stress via transforming growth factor-β/Smad3 signalling pathway in vivo and in vitro.
Wu X; Guan Y; Yan J; Liu M; Yin Y; Duan J; Wei G; Hu T; Weng Y; Xi M; Wen A
J Pharm Pharmacol; 2015 Aug; 67(8):1054-65. PubMed ID: 25864844
[TBL] [Abstract][Full Text] [Related]
12. Nimbolide ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibition of TGF-β and EMT/Slug signalling.
Annaldas S; Saifi MA; Khurana A; Godugu C
Mol Immunol; 2019 Aug; 112():247-255. PubMed ID: 31202101
[TBL] [Abstract][Full Text] [Related]
13. KCa3.1: a new player in progressive kidney disease.
Huang C; Pollock CA; Chen XM
Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):61-6. PubMed ID: 25415613
[TBL] [Abstract][Full Text] [Related]
14. Novel Targets for Therapy of Renal Fibrosis.
Prakoura N; Hadchouel J; Chatziantoniou C
J Histochem Cytochem; 2019 Sep; 67(9):701-715. PubMed ID: 31116064
[TBL] [Abstract][Full Text] [Related]
15. How does TGF-β mediate tubulointerstitial fibrosis?
Gewin L; Zent R
Semin Nephrol; 2012 May; 32(3):228-35. PubMed ID: 22835453
[TBL] [Abstract][Full Text] [Related]
16. Let-7c-5p Is Involved in Chronic Kidney Disease by Targeting TGF-
Wang Z; Zhou C; Sun Y; Chen Y; Xue D
Biomed Res Int; 2020; 2020():6960941. PubMed ID: 32626757
[TBL] [Abstract][Full Text] [Related]
17. TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?
Muñoz-Félix JM; González-Núñez M; Martínez-Salgado C; López-Novoa JM
Pharmacol Ther; 2015 Dec; 156():44-58. PubMed ID: 26493350
[TBL] [Abstract][Full Text] [Related]
18. Emerging strategies to disrupt the central TGF-β axis in kidney fibrosis.
Rauchman M; Griggs D
Transl Res; 2019 Jul; 209():90-104. PubMed ID: 31085163
[TBL] [Abstract][Full Text] [Related]
19. Role of the TGF-β/BMP-7/Smad pathways in renal diseases.
Meng XM; Chung AC; Lan HY
Clin Sci (Lond); 2013 Feb; 124(4):243-54. PubMed ID: 23126427
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-like protein 2 increases renal fibrosis by accelerating transforming growth factor-β signaling in chronic kidney disease.
Morinaga J; Kadomatsu T; Miyata K; Endo M; Terada K; Tian Z; Sugizaki T; Tanigawa H; Zhao J; Zhu S; Sato M; Araki K; Iyama K; Tomita K; Mukoyama M; Tomita K; Kitamura K; Oike Y
Kidney Int; 2016 Feb; 89(2):327-41. PubMed ID: 26806834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
